White House Report Outlines Push to Bolster Cancer Research

Big companies including Uber and Microsoft have committed to the effort

Vice President Joe Biden.

Join Our Community of Science Lovers!

By Reuters Staff

WASHINGTON (Reuters) - U.S. Vice President Joseph Biden's Cancer Moonshot initiative to speed the develop of cancer treatments has made some important strides such as increased information sharing among researchers but still faces challenges in many areas, according to a report out Monday.

The White House is still seeking about $700 million from Congress for the project. With Democratic President Barack Obama leaving office in January, it is also unclear how much of the initiative will continue under a new administration.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Microsoft Corp and Amazon.com Inc have committed to create cloud storage for the effort, according to the report that summarizes the work completed so far and outlines a path forward over the next five years. (Report: http://bit.ly/1TzXAkk)

Ride-sharing services Uber Technologies Inc and Lyft will help patients get to the doctor and to clinical trials.

"I'm going to devote the rest of my life to working on this, and I think we're perilously close to making some gigantic progress," Biden told reporters.

The $1 billion moonshot project was announced by Obama during his State of the Union address in January. Since then Biden, whose son Beau died last year at age 46 from brain cancer, has announced multiple investments and collaborations in support of the project.

The Cancer Moonshot initiative has also spurred Defense Department to use artificial intelligence to analyze its collection of tissue from tumors to look for patterns.

The U.S. Patent and Trademark Office has launched a pilot program to cut in half the time to review certain cancer therapy patent applications from an average of about two years to less than 12 months.

Obama praised Biden for his leadership on the issue and said his administration was laying the groundwork for future presidents to continue the fight against cancer.

"While we are going to be leaving soon, what I think we are going to be able to leave behind is an architecture and a framework" for advancing cancer research, Obama told reporters after his meeting with Biden.

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe